Literature DB >> 29665065

Atrial fibrillation symptom profiles associated with healthcare utilization: A latent class regression analysis.

Megan M Streur1, Sarah J Ratcliffe2, David J Callans3, M Benjamin Shoemaker4, Barbara J Riegel5.   

Abstract

BACKGROUND: Symptoms drive healthcare use among adults with atrial fibrillation, but limited data are available regarding which symptoms are most problematic and which patients are most at-risk. The purpose of this study was to: (1) identify clusters of patients with similar symptom profiles, (2) characterize the individuals within each cluster, and (3) determine whether specific symptom profiles are associated with healthcare utilization.
METHODS: We conducted a cross-sectional secondary data analysis of 1,501 adults from the Vanderbilt Atrial Fibrillation Registry. Participants were recruited from Vanderbilt cardiology clinics, emergency department, and in-patient services. Subjects included in our analysis had clinically verified atrial fibrillation and a completed symptom survey. Symptom and healthcare utilization data were collected with the University of Toronto Atrial Fibrillation Severity Scale. Latent class regression analysis was used to identify symptom clusters, with clinical and demographic variables included as covariates. We used Poisson regression to examine the association between latent class membership and healthcare utilization.
RESULTS: Participants were predominantly male (67%) with a mean age of 58.4 years (±11.9). Four latent classes were evident, including an Asymptomatic cluster (N = 487, 38%), Highly Symptomatic cluster (N = 142, 11%), With Activity cluster (N = 326, 25%), and Mild Diffuse cluster (N = 336, 26%). Highly Symptomatic membership was associated with the greatest rate of emergency department visits and hospitalizations (incident rate ratio 2.4, P < 0.001).
CONCLUSIONS: Clinically meaningful atrial fibrillation symptom profiles were identified that were associated with increased rates of emergency department visits and hospitalizations.
© 2018 Wiley Periodicals, Inc.

Entities:  

Keywords:  atrial fibrillation; emergency service; hospitalization; symptom cluster

Year:  2018        PMID: 29665065      PMCID: PMC6192872          DOI: 10.1111/pace.13356

Source DB:  PubMed          Journal:  Pacing Clin Electrophysiol        ISSN: 0147-8389            Impact factor:   1.976


  41 in total

1.  A middle-range theory of self-care of chronic illness.

Authors:  Barbara Riegel; Tiny Jaarsma; Anna Strömberg
Journal:  ANS Adv Nurs Sci       Date:  2012 Jul-Sep       Impact factor: 1.824

2.  Research electronic data capture (REDCap)--a metadata-driven methodology and workflow process for providing translational research informatics support.

Authors:  Paul A Harris; Robert Taylor; Robert Thielke; Jonathon Payne; Nathaniel Gonzalez; Jose G Conde
Journal:  J Biomed Inform       Date:  2008-09-30       Impact factor: 6.317

3.  Characterization of different subsets of atrial fibrillation in general practice in France: the ALFA study. The College of French Cardiologists.

Authors:  S Lévy; M Maarek; P Coumel; L Guize; J Lekieffre; J L Medvedowsky; A Sebaoun
Journal:  Circulation       Date:  1999-06-15       Impact factor: 29.690

4.  Symptom cluster research: conceptual, design, measurement, and analysis issues.

Authors:  Andrea M Barsevick; Kyra Whitmer; Lillian M Nail; Susan L Beck; William N Dudley
Journal:  J Pain Symptom Manage       Date:  2006-01       Impact factor: 3.612

Review 5.  Atrial fibrillation: profile and burden of an evolving epidemic in the 21st century.

Authors:  Jocasta Ball; Melinda J Carrington; John J V McMurray; Simon Stewart
Journal:  Int J Cardiol       Date:  2013-02-04       Impact factor: 4.164

6.  Increasing US emergency department visit rates and subsequent hospital admissions for atrial fibrillation from 1993 to 2004.

Authors:  Alden J McDonald; Andrea J Pelletier; Patrick T Ellinor; Carlos A Camargo
Journal:  Ann Emerg Med       Date:  2007-04-27       Impact factor: 5.721

7.  Augmented potassium current is a shared phenotype for two genetic defects associated with familial atrial fibrillation.

Authors:  Robert L Abraham; Tao Yang; Marcia Blair; Dan M Roden; Dawood Darbar
Journal:  J Mol Cell Cardiol       Date:  2009-07-30       Impact factor: 5.000

8.  Interpreting changes in quality of life in atrial fibrillation: how much change is meaningful?

Authors:  Paul Dorian; Caroline Burk; Christopher M Mullin; Rosemary Bubien; Donna Godejohn; Matthew R Reynolds; Dhanunjaya R Lakkireddy; Alan P Wimmer; Anil Bhandari; John Spertus
Journal:  Am Heart J       Date:  2013-07-01       Impact factor: 4.749

9.  Heart failure in patients with atrial fibrillation is associated with a high symptom and hospitalization burden: the RealiseAF survey.

Authors:  José Silva-Cardoso; Oleg J Zharinov; Piotr Ponikowski; Lisa Naditch-Brûlé; Thorsten Lewalter; Sandrine Brette; P Gabriel Steg
Journal:  Clin Cardiol       Date:  2013-09-17       Impact factor: 2.882

10.  Cardiac sodium channel (SCN5A) variants associated with atrial fibrillation.

Authors:  Dawood Darbar; Prince J Kannankeril; Brian S Donahue; Gayle Kucera; Tanya Stubblefield; Jonathan L Haines; Alfred L George; Dan M Roden
Journal:  Circulation       Date:  2008-03-31       Impact factor: 29.690

View more
  2 in total

1.  Multisymptom Profile Predicts Increased Risk of Poor Outcomes After Initial Placement of Implantable Cardioverter Defibrillator.

Authors:  Megan M Streur; Elaine A Thompson; Cynthia M Dougherty
Journal:  J Pain Symptom Manage       Date:  2019-11-09       Impact factor: 3.612

2.  Psychosocial and cognitive multimorbidity and health-related quality of life and symptom burden in older adults with atrial fibrillation: The systematic assessment of geriatric elements in atrial fibrillation (SAGE-AF) cohort study.

Authors:  Benita A Bamgbade; Saket R Sanghai; David D McManus; Darleen Lessard; Molly E Waring; Sarah Forrester; Isabelle Pierre-Louis; Jane S Saczynski
Journal:  Arch Gerontol Geriatr       Date:  2020-05-28       Impact factor: 3.250

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.